| PHI Pharmacist : Return and Reconstitution |
4467 |
| PHI Pharmacist : PHYSICAL VERIFICATION |
4461 |
| PHI Pharmacist : EXPIRY MANAGEMENT |
4458 |
| PHI Pharmacist : INDENTING AND RECEIPT |
4455 |
| PHI Pharmacist : PACKAGING |
4459 |
| PHI Pharmacist : ISSUE AND CONSUMPTION |
4456 |
| PHI Pharmacist : PATIENT-WISE BOXES |
4460 |
| PHI Pharmacist : STOCKING NTEP DRUGS IN PRIVATE SECTOR |
4457 |
| PHI Pharmacist : INFORMATION SYSTEMS IN NTEP SCM |
4454 |
| PHI Pharmacist : DR-TB TREATMENT AND CARE |
4452 |
| PHI Pharmacist : GENERAL CONCEPTS IN ADHERENCE MANAGEMENT |
4453 |
| PHI-Pharmacist: TB and TB Epidemiology |
4451 |
| CDST_LT: LPA Recording, interpretation and reporting |
4444 |
| CDST_LT: LPA Troubleshooting and quality assurance |
4445 |
| CDST_LT: LPA procedures |
4443 |
| CDST_LT: LPA lab biosafety requirements |
4435 |
| CDST_LT: Equipment used in LPA labs |
4442 |
| CDST_LT: Introduction to LPA |
4434 |
| CDST_LT: Molecular basics |
4433 |
| CDST_LT: MGIT DST quality control |
4430 |
| CDST_LT: Quality assurance of TB Culture & DST laboratories |
4431 |
| CDST_LT: MGIT 960 DST troubleshooting |
4429 |
| CDST_LT: False culture results |
4417 |
| CDST_LT: Inoculum preparation and incubation for MGIT DST |
4427 |
| CDST_LT: SIRE susceptibility testing |
4424 |
| CDST_LT: Storage of culture isolates |
4421 |
| CDST_LT: Liquid culture troubleshooting |
4418 |
| CDST_LT: Reading and reporting of MGIT 960 DST results |
4428 |
| CDST_LT: Pyrazinamide (PZA) susceptibility testing |
4425 |
| CDST_LT: LT DST Introduction |
4422 |
